Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3684-3691

  Grebe, Stefan K G ^a   McIver, Bryan ^a   Hay, Ian D ^a   Wu, Patricia S C ^b   Maciel, Lea M Z ^c   Drabkin, Harry A ^d   Goellner, John R ^a   Grant, Clive S ^a   Jenkins, Robert B ^a   Eberhardt, Norman L ^a,e  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^e ST MARY S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME 17P; CHROMOSOME 3P; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PLOIDY; PRIORITY JOURNAL; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 9844267964     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.11.3684     Document Type: Article

References (33)

1. Yokota J, Sugimura T. 1993 Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J. 7:920-925.
2. Kratzke RA, Shimizu E, Kaye FJ. 1992 Oncogenes in human lung cancer. Cancer Treat Res. 63:61-85.
3. Lane DP. 1994 p53 and human cancers. Br Med Bull. 50:582-599.
4. Herrmann MA, Hay ID, Bartelt Jr DH, et al. 1991 Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest. 88:1596-1604.
5. Zedenius J, Wallin G, Svensson A, Bovee J, Hoog A, and Backdahl M. 1996 Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum Genet. 97:299-303.
6. Hay ID. 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am. 19:545-567.
7. Ryan JJ, Hay ID, Grant CS, Rainwater LM, Farrow GM, Goellner JR. 1988 Flow cytometric measurements in benign and malignant Hürthle cell tumors of the thyroid. World J Surg. 12:482-487.
8. Hollstein M, Rice K, Greenblatt MS, et al. 1994 Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22:3551-3555.
9. Blaszyk H, Hartmann A, Schroeder JJ, McGovern RM, Sommer SS, Kovach JS. 1995 Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting. BioTechniques. 18:256-260.
10. Grebe SK, Hay ID. 1995 Follicular thyroid cancer. Endocrinol Metab Clinics North Am. 24:761-801.
11. Bondeson L, Bengtsson A, Bondeson AG, Dahlenfors R, Grimelius L, Mark J. 1989 Chromosome studies in thyroid neoplasia. Cancer. 64:680-685.
12. Teyssier JR, Liautaud-Roger F, Ferre D, Patey M, Dufer J. 1990 Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data. Cancer Genet Cytogenet. 50:249-263.
13. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H. 1988 Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene. 3:571-578.
14. Bystrom C, Larsson C, Blomberg C, et al. 1990 Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA. 87:1968-1972.
15. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. 1986 Localization of gene for human p53 tumor antigen to band 17p13. Nature. 320:84-85.
16. Yamakawa K, Takahashi E, Murata M, Okui K, Yokoyama S, Nakamura Y. 1992 Detailed mapping around the breakpoint of (3;8) translocation in familial renal cell carcinoma and FRA3B. Genomics. 14:412-416.
17. Hibi K, Takahashi T, Yamakawa K, et al. 1992 Three distinct regions involved in 3p deletion in human lung cancer. Oncogene. 7:445-449.
18. Gnarra JR, Lerman MI, Zbar B, Linehan WM. 1995 Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol. 22:3-8.
19. Chung DC, Louis DN, Graeme-Cook F, Smith AP, Warshaw AL, Arnold A. Evidence for a novel pancreatic islet cell tumor suppressor gene with clinical prognostic implications. Proc of the 10th Int Congr of Endocrinology. 1996; (Abstract P3-826) p 961.
20. Greco A, Mariani C, Miranda C, et al. 1995 The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol. 15:6118-6127.
21. Ohta M, Inoue H, Cotticelli MG, et al. 1996 The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3-8) breakpoint, is abnormal in digestive tract cancers. Cell. 84:587-597.
22. Brauch H, Pomer S, Hieronymus T, Schadt T, Lohrke H, Komitowski D. 1994 Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p. World J Urol. 12:162-168.
23. Waber PG, Lee NK, Nisen PD. 1996 Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer. Oncogene. 12:365-369.
24. Gnarra JR, Tory K, Weng Y, et al. 1994 Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet. 7:85-90.
25. Herman JG, Latif F, Weng Y, et al. 1994 Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA. 91:9700-9704.
26. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP. 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest. 91:179-184.
27. Chang F, Syrjanen S, Syrjanen K. 1995 Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol. 13:1009-1022.
28. Nagai MA, Pacheco MM, Brentani MM, et al. 1994 Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients. Br J Cancer. 69:754-758.
29. Cornelis RS, van Vliet M, Vos CB, et al. 1994 Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res. 54:4200-4206.
30. Phillips NJ, Ziegler MR, Radford DM, et al. 1996 Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res. 56:1996.
31. Cogen PH, Daneshvar L, Metzger AK, Duyk G, Edwards MS, Sheffield VC. 1992 Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet. 50:584-589.
32. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU. 1992 Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res. 52:6716-6721.
33. Farid NR, Shi Y, Zou M. 1994 Molecular basis of thyroid cancer. Endocr Rev. 15:202-232.